These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases]. Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281 [TBL] [Abstract][Full Text] [Related]
3. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases]. Shibata K; Dohi K; Fujii Y; Ishikawa H Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):719-29. PubMed ID: 1770632 [TBL] [Abstract][Full Text] [Related]
4. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis]. Bobkova IN; Kozlovskaia LV; Rameeva AS; Varshavskiĭ VA; Golitsyna EP Ter Arkh; 2007; 79(6):10-5. PubMed ID: 17684960 [TBL] [Abstract][Full Text] [Related]
5. [Significance of urinary fibrin/fibrinogen degradation product (FDP) D-dimer measured by highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases]. Shibata T; Magari Y; Mizunaga S; Okabe E; Sumie A; Ishii T; Tomo T; Yasumori R; Nasu M Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):805-12. PubMed ID: 8072218 [TBL] [Abstract][Full Text] [Related]
7. [Intraglomerular coagulation in patients with glomerulonephritis, with special reference to FDP D-dimer]. Shibata T; Ura S; Hirai Y; Taura K; Harada T; Hara K Nihon Naika Gakkai Zasshi; 1983 Sep; 72(9):1143-9. PubMed ID: 6663183 [No Abstract] [Full Text] [Related]
8. Deposition of fibrin-stabilizing factor (F XIIIA and S), fibrinogen-related antigens, fibrinogen degradation products (FDPd and FDPe) and antihemolytic factor (F VIII) in renal disease: analysis of 161 cases by immunofluorescence microscopy. Colasanti G; Morel Maroger L; D'Amico G Clin Nephrol; 1987 Jul; 28(1):28-34. PubMed ID: 3113791 [TBL] [Abstract][Full Text] [Related]
9. Urinary fibrin-fibrinogen degradation products and intraglomerular fibrin-fibrinogen deposition in various renal diseases. Kamitsuji H; Tani K; Taniguchi A; Masuyama H; Iida Y; Fukui H Thromb Res; 1981 Feb; 21(3):285-94. PubMed ID: 7245140 [No Abstract] [Full Text] [Related]
10. Exploration of intraglomerular phenomena by measurement of the level of fibrin degradation products in the renal vein blood. Conte J; Boneu B; Mignon-Conte ; Suc JM Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):915-26. PubMed ID: 4807811 [No Abstract] [Full Text] [Related]
12. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases. Kaizu K; Ito Y; Uriu K; Eto S Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397 [TBL] [Abstract][Full Text] [Related]
13. [Correlation between products of fibrin degradation and platelet dysfunction in chronic renal failure. Effects of aspirin]. Lazzari MA; Pavlovsky M; Martínez Canaveri A Medicina (B Aires); 1977; 37(2):97-105. PubMed ID: 895494 [No Abstract] [Full Text] [Related]
14. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases. Shibata T; Magari Y; Kamberi P; Ishii T; Tomo T; Yasumori R; Nasu M Clin Nephrol; 1995 Aug; 44(2):91-5. PubMed ID: 8529315 [TBL] [Abstract][Full Text] [Related]
15. [Fibrin fibrinogen degradation products and their significance in kidney diseases (literature review)]. Peleshchuk AP; Belitskaia GA; Ena IaM; Drannik GN Vrach Delo; 1979 Aug; (8):1-5. PubMed ID: 384672 [No Abstract] [Full Text] [Related]
16. [Evaluation of factors influencing platelet aggregation in patients with chronic glomerulonephritis (CGN)]. Zdrojewski Z; Raszeja-Specht A; Kustosz J; Skibowska A; Rutkowski B Przegl Lek; 1996; 53(5):434-8. PubMed ID: 8754409 [TBL] [Abstract][Full Text] [Related]
17. Urinary fibrin degradation products in childhood acute nephritis. Dawson KP N Z Med J; 1977 Oct; 86(597):332-4. PubMed ID: 272538 [TBL] [Abstract][Full Text] [Related]
18. On the origin of urinary fibrin-fibrinogen-related antigen in glomerulonephritis. Bone JM; Sherman LA; Valdes AJ; Lubowitz H J Lab Clin Med; 1977 May; 89(5):1043-52. PubMed ID: 558266 [TBL] [Abstract][Full Text] [Related]
19. [Urinary excretion of fibrin degradation products in children with nephrotic syndrome (author's transl)]. Bouissou F; Barthe P; Boneu B Arch Fr Pediatr; 1980 Mar; 37(3):167-71. PubMed ID: 7469695 [TBL] [Abstract][Full Text] [Related]
20. Enhanced glomerular procoagulant activity and fibrin deposition in rats with mercuric chloride-induced autoimmune nephritis. Kanfer A; de Prost D; Guettier C; Nochy D; Le Floch V; Hinglais N; Druet P Lab Invest; 1987 Aug; 57(2):138-43. PubMed ID: 3475499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]